Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
This activity is supported by an educational grant from Lilly.
For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.
In order to request this CME/CE activity for your center, please contact Samantha Zelasko at SZelasko@gotoper.com or call (609) 325-4668
Oncology Best Practice™:
Optimizing Outcomes when Quality Is Being Measured: A Focus on Evidence-Based Care for Gastric and Gastroesophageal Junction Cancer Treatment
April 2017-June 2018
In patients with advanced gastric cancers, novel strategies across multiple lines of therapy can be personalized based on tumor characteristics. Other approaches can offer options to patients that may mitigate toxicity by obviating the need for more toxic therapies. Knowledge of key trials should inform clinical decision making and allow for optimized treatment sequencing and proactive mitigation of predictable treatment-related toxicities for patients with these most difficult-to-treat solid tumors.
Accordingly, there is a need for educational activities targeted to community practitioners that illustrate how to consider and apply key data sets in the context of the real world scenarios these clinicians routinely encounter in their practice settings. To meet these educational needs, this series of programs has recruited national experts who can synthesize data sets on newly available and late-stage investigational strategies to manage advanced gastric cancers and can assist community practitioners in optimizing outcomes for their patients.
Key Topics to be Addressed
This activity is directed toward community oncologists, nurses, and pharmacists who treat or manage patients with gastric cancer or gastroesophageal junction cancers. Fellows, nurse practitioners, physician assistants, researchers, and other healthcare professionals interested in the treatment or management of these tumors are also invited to participate.
Upon completion of this activity, participants will be better prepared to:
ONS: PER Forum™: Nursing Opportunities to Improve Outcomes With the Advent of PARP Inhibitors in the Care of Women’s Cancers
May 17, 2018
ONS: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for Nurses
May 17, 2018
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of Cancers
May 30, 2018
May 31, 2018
May 31, 2018